Miriam P.
- Country
- Germany
- Department
- Kardiologie und Pneumolog
Research Overview
Data & Insights
Has run more than one trial at 0 of 13 partner sites.
Specializations
Cardiovascular Therapeutics
The investigator specializes in studying antifibrotic therapy approaches for patients with severe aortic conditions, particularly focusing on treatment strategies following transcatheter aortic valve implantation (TAVI).
- Aortic Stenosis Management
- Myocardial Fibrosis Treatment
- Post-TAVI Care
This research explores therapeutic interventions for patients with high fibrotic burden.
Cardiac Imaging
The investigator utilizes advanced cardiac magnetic resonance imaging (CMR) techniques to evaluate and monitor myocardial conditions and treatment outcomes.
- Late Gadolinium Enhancement Assessment
- Extracellular Volume Fraction Analysis
- Matrix Volume Measurements
Expertise includes quantification of both replacement and interstitial fibrosis.
Therapeutic Innovation
The investigator explores combination therapies including spironolactone and dihydralazine for cardiac tissue remodeling.
- Antifibrotic Treatment Development
- Combination Therapy Evaluation
- Standard of Care Enhancement
Research focuses on innovative therapeutic approaches for cardiac fibrosis regression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.